Company Filing History:
1 out of 6 
1 out of 12 
1 out of 5,094 
Years Active: 2023
Title: Sébastien Faraj: Innovator in Cancer Therapeutics
Introduction
Sébastien Faraj is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer therapeutics through his innovative research and development efforts. His work focuses on improving the therapeutic potential of drugs using advanced methodologies.
Latest Patents
Sébastien Faraj holds a patent titled "Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs." This patent discloses a method for delivering an anti-cancer agent into a cell that expresses the O-acetylated GD2 ganglioside by utilizing an antibody that recognizes this specific ganglioside. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Sébastien has worked with prominent organizations such as Ogd2 Pharma and Nantes Université. His roles in these institutions have allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Sébastien has collaborated with notable colleagues, including Stéphane Birkle and Julien Fleurence. These partnerships have further enriched his research and development endeavors.
Conclusion
Sébastien Faraj is a dedicated inventor whose work in cancer therapeutics has the potential to make a significant impact on treatment methodologies. His innovative approach and collaborations highlight his commitment to advancing healthcare solutions.